Effect of screening on ovarian cancer mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial

JAMA

Volumn 305, Issue 22, 2011, Pages 2295-2302

  Buys, Saundra S ^a   Partridge, Edward ^b   Black, Amanda ^c   Johnson, Christine C ^e   Lamerato, Lois ^e   Isaacs, Claudine ^f   Reding, Douglas J ^g   Greenlee, Robert T ^g   Yokochi, Lance A ^h   Kessel, Bruce ^h   Crawford, E David ⁱ   Church, Timothy R ^j   Andriole, Gerald L ^k   Weissfeld, Joel L ^l   Fouad, Mona N ^b   Chia, David ^m   O'Brien, Barbara ⁿ   Ragard, Lawrence R ⁿ   Clapp, Jonathan D ^o   Rathmell, Joshua M ^o   Riley, Thomas L ^o   Hartge, Patricia ^c   Pinsky, Paul F ^c   Zhu, Claire S ^c   Izmirlian, Grant ^c   Kramer, Barnett S ^c   Miller, Anthony B ^p   Xu, Jian Lun ^q   Prorok, Philip C ^c   Gohagan, John K ^d   Berg, Christine D ^c   more..

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e HENRY FORD HEALTH SYSTEM   (United States)

^f GEORGETOWN UNIVERSITY   (United States)

^g MARSHFIELD CLINIC   (United States)

^h PACIFIC HEALTH RESEARCH AND EDUCATION INSTITUTE   (United States)

ⁱ UNIVERSITY OF COLORADO   (United States)

^j UNIVERSITY OF MINNESOTA   (United States)

^k WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ WESTAT   (United States)

^o INFORMATION MANAGEMENT SERVICES INC   (United States)

^p UNIVERSITY OF TORONTO   (Canada)

^q NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CAUSE OF DEATH; CONTROLLED STUDY; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; OVARIECTOMY; OVARY CANCER; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSVAGINAL ECHOGRAPHY;

EID: 79958036419     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.766     Document Type: Article

References (22)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225-249.
2. Jacobs IJ, Skates SJ, MacDonald N, et al. Screening for ovarian cancer: a pilot randomised controlled trial. Lancet. 1999;353(9160):1207-1210. (Pubitemid 29168457)
3. Gohagan JK, Prorok PC, Hayes RB, Kramer BS; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials. 2000;21(6)(suppl):251S- 272S.
4. Kobayashi H, Yamada Y, Sado T, et al. A randomized study of screening for ovarian cancer: a multicenter study in Japan. Int J Gynecol Cancer. 2008;18(3):414-420. (Pubitemid 351668303)
5. Prorok PC, Andriole GL, Bresalier RS, et al; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000;21(6)(suppl):273S-309S.
6. Buys SS, Partridge E, Greene MH, et al; PLCO Project Team. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol. 2005;193(5):1630-1639. (Pubitemid 41540458)
7. Simpson NK, Johnson CC, Ogden SL, et al; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team. Recruitment strategies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: the first six years. Control Clin Trials. 2000;21(6)(suppl):356S-378S.
8. Stallings FL, Ford ME, Simpson NK, et al; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team. Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000;21(6)(suppl):379S-389S.
9. Hayes RB, Reding D, Kopp W, et al; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team. Etiologic and early marker studies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000;21(6)(suppl):349S-355S.
10. Weissfeld JL, Fagerstrom RM, O'Brien B; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team. Quality control of cancer screening examination procedures in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000;21(6)(suppl):390S-399S.
11. Miller AB, Yurgalevitch S, Weissfeld JL; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team. Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000;21(6)(suppl): 400S-406S.
12. Proschan MA, Lan KKG, Wittes JT. Statistical Monitoring of Clinical Trials: A Unified Approach. New York, NY: Springer-Verlag; 2006.
13. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2010.
14. Izmirlian G. Estimation of the relative risk following group sequential procedure based upon the weighted log-rank statistic. http://arxiv.org/abs/1102. 5088. Accessibility verified May 10, 2011.
15. Ahlbom A. Biostatistics for Epidemiologists. Boca Raton, FL: Lewis; 1993.
16. Brown PO, Palmer C. The preclinical natural history of serous ovarian cancer: defining the target for early detection. PLoS Med. 2009;6(7):e1000114.
17. Skates SJ, Menon U, MacDonald N, et al. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women. J Clin Oncol. 2003;21(10)(suppl):206S-210S.
18. Menon U, Skates SJ, Lewis S, et al. Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer. J Clin Oncol. 2005;23(31):7919-7926. (Pubitemid 46657391)
19. Menon U, Gentry-Maharaj A, Hallett R, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009;10(4):327-340.
20. Havrilesky LJ, Sanders GD, Kulasingham S, et al. Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reductions. Cancer. 2011;117(3):545-553.
21. Partridge E, Kreimer AR, Greenlee RT, et al; PLCO Project Team. Results from four rounds of ovarian cancer screening in a randomized trial. Obstet Gynecol. 2009;113(4):775-782.
22. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med. 1998;338(16):1089-1096. (Pubitemid 28227478)